Category Archives: Analgesia and anesthesia

PowerPoint on general anesthesia and anesthetic agents

Dr. Ravindra S.Beedimani shared one of his PowerPoint lectures with Pharmamotion readers, the topic here is “Pharmacology of general anesthesia”. Dr. Beedimani is Associate Professor in Pharmacology at American University of the Caribbean, School of Medicine, St. Maarten, Netherlands Antilles. If you are interested in contributing to this blog, just send an e-mail to pharmamotion@gmail.comContinue Reading

Updated SIGN clinical guideline: Pain management in adults with cancer

The Scottish Intercollegiate Guidelines Network (SIGN) updated a clinical guideline entitled “Control of pain in adults with cancer”.  An outline of the contents (drug therapy related) in this guideline for the treatment of cancer induced pain include: Principles of pain management: introduction, World Health Organization cancer pain relief programme, using the WHO ladder. Treatment with…

Methylnaltrexone (Relistor): clinical updates from two independent sources

Methylnaltrexone (Relistor) is a peripherally-acting μ-opioid antagonist used for the treatment of opioid induced constipation. Two independent organizations have recently published updated clinical information on this drug: Australian Prescriber. New drugs: Methylnaltrexone Health Canada. Summary Basis of Decision (SBD) RELISTOR The Scottish Medicines Consortium also reviewed Relistor in January 2009.

Ionsys (fentanyl hydrochloride): EMEA recommends the suspension of its marketing authorisation

Press release about the suspension of Ionsys (fentanyl hydrochloride) marketing authorisation The European Medicines Agency (EMEA) has recommended the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride), from Janssen-Cilag International NV, because of a defect with the delivery system of the medicine that could lead to patients being overdosed. Ionsys is a system for the transdermal…

Tapentadol approved by FDA as treatment for moderate to severe pain

FDA news release about the approval of pentadol to alleviate moderate to severe Pain: The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain. Tapentadol is a centrally-acting synthetic analgesic that is available in doses of 50 mg, 75 mg, or 100…

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos